×

AstraZeneca sinks on failed lung cancer study

7:34 AM ET Thu, 27 July 2017

CNBC's Meg Tirrell reports shares of the pharmaceutical giant are having a bad day after the company's experimental lung cancer drug failed to pass a major test.